Marseille, France

Frederic Chavane

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Commissariat a L'energie Atomique Et Aux Energies Alternatives. Active years: 2019.


 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Frederic Chavane: Innovator in Prosthetic Vision Rehabilitation

Introduction

Frederic Chavane is a notable inventor based in Marseilles, France. He has made significant contributions to the field of prosthetic vision rehabilitation. His innovative work focuses on developing devices that enhance the quality of life for individuals with visual impairments.

Latest Patents

Chavane holds a patent for a "Device and method for prosthetic rehabilitation of the retina." This device is designed to assist in prosthetic vision rehabilitation. It includes a scleral explant that is shaped to make contact with at least one portion of the sclera of an eye. Additionally, it features at least one inducer arranged on the scleral explant. This invention represents a significant advancement in the field of vision rehabilitation.

Career Highlights

Frederic Chavane is affiliated with the Commissariat à l'Énergie Atomique et aux Énergies Alternatives. His work at this institution has allowed him to collaborate with other experts in the field. He has dedicated his career to improving prosthetic solutions for vision rehabilitation.

Collaborations

Chavane has worked alongside talented colleagues, including Myriam Pannetier-Lecoeur and Vincent Trauchessec. Their collaborative efforts have contributed to the advancement of technologies aimed at enhancing visual rehabilitation.

Conclusion

Frederic Chavane's innovative contributions to prosthetic vision rehabilitation highlight his commitment to improving the lives of those with visual impairments. His work continues to inspire advancements in the field of medical technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…